Cellebrite DI (CLBT) Gains from Investment Securities: 2020-2025
Historic Gains from Investment Securities for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $4.7 million.
- Cellebrite DI's Gains from Investment Securities fell 93.43% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $414,000, marking a year-over-year decrease of 99.83%. This contributed to the annual value of $110.7 million for FY2024, which is 224.51% up from last year.
- According to the latest figures from Q3 2025, Cellebrite DI's Gains from Investment Securities is $4.7 million, which was up 152.78% from -$8.9 million recorded in Q2 2025.
- In the past 5 years, Cellebrite DI's Gains from Investment Securities registered a high of $134.8 million during Q2 2024, and its lowest value of -$17.1 million during Q1 2022.
- Over the past 3 years, Cellebrite DI's median Gains from Investment Securities value was $9.8 million (recorded in 2023), while the average stood at $28.6 million.
- As far as peak fluctuations go, Cellebrite DI's Gains from Investment Securities slumped by 1,082.01% in 2021, and later spiked by 3,369.86% in 2024.
- Cellebrite DI's Gains from Investment Securities (Quarterly) stood at -$15.5 million in 2021, then skyrocketed by 102.42% to $375,000 in 2022, then surged by 2,509.33% to $9.8 million in 2023, then crashed by 61.15% to $3.8 million in 2024, then slumped by 93.43% to $4.7 million in 2025.
- Its Gains from Investment Securities stands at $4.7 million for Q3 2025, versus -$8.9 million for Q2 2025 and $806,000 for Q1 2025.